share_log

金达威(002626.SZ):未来将利用合成生物技术布局生物代糖

Kim Dawei (002626.SZ): In the future, synthetic biotechnology will be used to lay out biosaccharides

Gelonghui Finance ·  May 16 05:56

Gelonghui, May 16, 丨 Jin Dawei (002626.SZ) held a performance briefing on May 16, 2024 to discuss “What products are the synthetic biotechnology currently used in the company, and what new products does it plan to use synthetic biotechnology to develop in the future?” The company replied that the company has used synthetic biotechnology in the production of products such as coenzyme Q10, NMN, NADH, vitamin K2, nattokinase, PQQ, adenosylmethionine, DHA, ARA, etc., and also uses synthetic biology to lay out new products, such as astaxanthin, inositol, calcium pantothenate, etc. In the future, the company will use synthetic biotechnology to lay out biosaccharide series products such as allodonose and tag sugar.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment